Transaction #31724 · Form 4 · 0001493152-26-046032
ChronoScale Holdings Corp · Stock award · Common Stock
ChronoScale Holdings Corp · Transacted October 2, 2026 · Filed October 6, 2026
What does this filing report?
An SEC Form 4 filing for ChronoScale Holdings Corp records a stock award involving Common Stock on October 2, 2026. The reported quantity was 51,626. The filing date is October 6, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- ChronoScale Holdings Corp
- Company CIK
- 0001549084
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 51,626
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 239,760
- Ownership description
- Not reported
- SEC acceptance time
- Oct 6, 2026, 6:19 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Davis Scott G. ↗
Director
CIK 0001908860
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The restricted stock units ("RSUs") were granted on October 2, 2026 in connection with the consummation of the disposition of Ekso Bionics, Inc., a wholly owned subsidiary of ChronoScale Holdings Corporation (the "Issuer"), and vested in full on the grant date. Effective as of October 3, 2026, the Reporting Person resigned as a member of the board of directors of the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer and has no expiration date.
- F2
- Settlement of the RSUs has been deferred in accordance with the terms of the award agreement.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.